HIGHLIGHTS
- who: Zhan Wang and collaborators from the Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China have published the Article: Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases, in the Journal: (JOURNAL)
SUMMARY
NIC Regulates Cancer Cell Stemness Elevated mitochondrial biogenesis and/or metabolism are distinguishing features of cancer cells, as well as cancer stem_cells (CSCs), which are involved in tumor initiation, metastatic dissemination, and therapy resistance. Combined treatment with NIC and an inhibitor of oxidative_phosphorylation termed dodecyl-TPP (d-TPP) can reduce the proliferation of tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.